alert icon Coronavirus
Now scheduling COVID-19 vaccines for ages 5+, boosters and third doses
Schedule your appointment
COVID-19 vaccine FAQs

Going to a Cleveland Clinic location?
New visitation guidelines
Masks required for patients and visitors (even if you're vaccinated)

Xiangling Wang, MD, PhD

Xiangling Wang, MD, PhD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Center for Personalized Genetic Healthcare
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No


Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Xiangling Wang, MD, PhD

Xiangling Wang, MD, PhD, is a Staff Physician in Cleveland Clinic’s Genomic Medicine Institute. She sees patients on Main Campus.

Dr. Wang is certified by the American Board of Medical Genetics and Genomics, and earned a certificate from the Educational Commission for Foreign Medical Graduates. She earned her medical degree from Shandong Medical University in Jinan, China, and her doctor of philosophy degree from the Shanghai Jiaotong University, in Shanghai, China. Her post-graduate training includes an internal medicine residency at the Shandong Medical University in Jinan, China, and a medical genetics residency at the Mayo Clinic, in Rochester, Minnesota. Additionally, Dr. Wang completed a fellowship in nephrology at the University of Texas Southwestern Medical Center in Dallas Texas, and Loma Linda University in Loma Linda, California.

Prior to joining Cleveland Clinic, Dr. Wang practiced as a faculty nephrologist in the Medical School of Shanghai Jiaotong University and as assistant professor of Medicine at the Mayo Clinic. Dr. Wang has published more than 20 major, peer-reviewed papers and presented at numerous national and international conferences. Dr. Wang is a member of the American Medical Association, the American College of Medical Genetics and the American Society of Nephrology.  She is also an invited reviewer for the following journals: Biomedical and Environmental Sciences, Clinical and Experimental Immunology, Diabetic Research and Clinical Practice, and reviewed abstracts for the 2018 annual meeting of the American Society of Nephrology.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Loma Linda University
Loma Linda, CA USA

Fellowship - UT Southwestern at Dallas
Dallas, TX USA

Residency - Mayo Clinic
Medical Genetics
Phoenix, AZ USA

Graduate School - Shanghai Jiao Tong University

Residency - Shandong University Medical School
Internal Medicine
Jinan Shandong, China

Medical Education - Shandong University Medical School
Jinan Shandong, China


  • Medical Genetics and Genomics - Clinical Genetics and Genomics
Research & Publications

Research & Publications

See publications for Xiangling Wang, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/17/2021, Dr. Wang has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Xiangling Wang, MD, PhD

Related Videos Featuring Xiangling Wang, MD, PhD

Back to Top